Global Health Ltd Analyst Rating
based on 12 analysts
41.67%
Buy
41.67%
Hold
16.67%
Sell
Based on 12 analysts offering long term price targets for Global Health Ltd. An average target of ₹1184.25
Source: S&P Global Market Intelligence
Global Health Ltd Share analysis
Global Health Ltd price forecast by 12 analysts
Upside of3.77%
High
₹1440
Target
₹1184.25
Low
₹855
Global Health Ltd target price ₹1184.25, a slight upside of 3.77% compared to current price of ₹1124. According to 12 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Global Health Ltd revenue growth forecast
Expected growth rate Q1, FY2026:60.37%
Forecast
Actual
Including amortisation and stock based compensations
Global Health Ltd EPS growth forecast
EPS estimate Q1, FY2026:97.04%
Forecast
Actual
Source: S&P Global Market Intelligence
Global Health Ltd Performance
Day's Low
Day's High
₹1,113.95₹1,164.352 Week's Low
52 Week's High
₹908₹1,513.9
| Returns % | |
| 1 Month Return | + 6.59 % |
| 3 Month Return | + 2.13 % |
| 1 Year Return | + 22.32 % |
| Market Stats | |
| Previous Close | ₹1,141.25 |
| Open | ₹1,141.00 |
| Volume | 8.60L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹30,628.36Cr |
Global Health Ltd Key Statistics
| P/E Ratio | 62.78 |
| PEG Ratio | 21.87 |
| Market Cap | ₹30,628.36 Cr |
| P/B Ratio | 12.48 |
| EPS | 12.16 |
| Dividend Yield | 0 |
| Sector | Healthcare |
| ROE | 13.52 |
Global Health Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹30,628.36 Cr | 34.96% | 0.55 | ₹326 Cr | ₹2,694 Cr | |
| BUY | ₹5,354.98 Cr | 18.04% | 0.54 | ₹69 Cr | ₹571 Cr | |
| NA | ₹34.65 Cr | -15.12% | 0.67 | NA | NA | |
| NA | ₹78.30 Cr | 29.96% | 0.56 | -₹2 Cr | ₹39 Cr | |
| BUY | ₹24,276.33 Cr | 45.18% | 0.61 | ₹211 Cr | ₹3,698 Cr |
Global Health Ltd Mutual Fund Holdings
About Global Health Ltd
issuing 500 crores in fresh issue and 1,705.57 crores in offer for sale. Finally, it came out with a public issue in November 2022, raising a total of Rs. 2,205.57 crores. Global Health Limited (GHL) is among the leading private medical care providers operating from the North and East regions of India. Founded by Dr Naresh Trehan, a renowned cardiovascular and cardiothoracic surgeon, GHL has a network of five hospitals spread across the country and provides healthcare services over 30 medical specialties. Their flagship hospital in Gurugram was opened in November 2009 and had 200 installed beds along with 50 doctors across specialties. The Patna hospital is larger and has 228 installed beds, designed to accommodate over 500, and employs over 125 doctors. To finance capital expenditure and general corporate purposes, GHL held an initial public offering in January 2021, seeking to raise 500 crores in fresh issue and 1,705.57 crores in offer for sale. The successful public issue in November 2022 allowed GHL to raise total of Rs. 2,205.57 crores.
Share Price: ₹1124.00 per share as on 11 Dec, 2024 04:01 PM
Market Capitalisation: ₹30,628.36Cr as of today
Revenue: ₹956.56Cr as on September 2024 (Q3 24)
Net Profit: ₹130.82Cr as on September 2024 (Q3 24)
Listing date: 16 Nov, 2022
Chairperson Name: Naresh Kumar Trehan
| Organisation | Global Health Ltd |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Global Health Ltd
Global Health Reports Strong Q3 Growth in 2024 - 04 Dec, 2024
Global Health's consolidated net sales for September 2024 reached Rs 956.56 crore, a 13.34% increase year-over-year. Net profit rose 4.52% to Rs 130.82 crore, while EBITDA increased by 5.52%. EPS also improved to Rs 4.87 from Rs 4.66.Global Health Ltd: Positive Outlook with New Hospital Plans - 02 Dec, 2024
Axis Securities recommends a BUY rating for Global Health Ltd, targeting Rs 1,200/share, citing a new 500+ bed hospital in Mumbai expected to generate significant revenue and profit.Global Health Reports Strong Q3 Growth - 27 Nov, 2024
Global Health's standalone net sales for September 2024 reached Rs 664.61 crore, marking a 14.56% year-on-year increase. The net profit for the period was Rs 104.47 crore, reflecting solid financial performance.Global Health Reports Strong Q2 Results Amid Challenges - 17 Nov, 2024
Global Health's Q2 results show a 4.54% profit increase to ₹130.84 crore and a 13.34% revenue rise to ₹956.55 crore. Despite rising expenses, the company maintains an 11.76% year-to-date return and a consensus Buy recommendation from analysts.Medanta Reports Strong Q2 FY25 Financial Performance - 15 Nov, 2024
Medanta achieved record quarterly revenue of Rs 974.8 crore in Q2 FY25, with a net profit of Rs 130.8 crore, reflecting robust growth across its hospital network and services.Global Health Reports Strong Q2 Results and Stock Surge - 14 Nov, 2024
Global Health Ltd announced a 5% increase in Q2 net profit to Rs 131 crore, with revenue rising to Rs 957 crore. Following these results, shares surged by 2%. A brokerage has set a target price of Rs 1,146 for the stock, which is currently trading at Rs 1,071.95.Global Health Announces New Hospital, Shares Rise - 07 Nov, 2024
Global Health (Medanta) shares increased over 2% following the announcement of a new 750-bed super specialty hospital in New Delhi, with a ₹600 crore investment planned over the next three to four years.Global Health to Manage New 750-Bed Hospital - 06 Nov, 2024
Global Health Ltd has signed an operations and management agreement to operate a 750-bed super specialty hospital in Pitampura, New Delhi, with a projected investment of Rs 600 crore over the next 3-4 years. The hospital aims to address growing healthcare needs in the region and will commence operations in approximately four years.
Insights on Global Health Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 9.03% to 9.59% in Sep 2024 quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 43.44% to 43.65% in Sep 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 836.05 Cr → 974.77 Cr (in ₹), with an average increase of 7.4% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 106.29 Cr → 130.84 Cr (in ₹), with an average increase of 18.8% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 33.04% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Fortis Healthcare Ltd has given 84.9% return, outperforming this stock by 62.6%
NEGATIVE IMPACTPrice Dip
In the last 7 days, MEDANTA stock has moved down by -1.8%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 12.94% to 12.20% in Sep 2024 quarter
Global Health Ltd Financials
Index Inclusions
Global Health Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 33.04% | ||
| Foreign Institutions | 12.2% | ||
| Mutual Funds | 9.59% | 6.15 | |
| Retail Investors | 43.65% | 0.47 | |
| Others | 1.52% |
Global Health Ltd Key Indicators
Global Health Ltd Valuation
Global Health Ltd in the last 5 years
Lowest (37.92x)
April 6, 2023
Today (62.78x)
December 10, 2024
Industry (104.27x)
December 10, 2024
Highest (88.30x)
February 23, 2024
Global Health Ltd Earnings and Dividends
Global Health Ltd Earnings Results
Global Health Ltd’s net profit jumped 4.54% since last year same period to ₹130.84Cr in the Q2 2024-2025. On a quarterly growth basis, Global Health Ltd has generated 23.1% jump in its net profits since last 3-months.
Read More about Earnings Results
Global Health Ltd Technicals Summary
Bearish
Neutral
Bullish
Global Health Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Global Health Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Global Health Ltd shares.
Global Health Ltd (MEDANTA) share price today is ₹1124
Global Health Ltd is listed on NSE
Global Health Ltd is listed on BSE
- Today’s highest price of Global Health Ltd is ₹1164.3.
- Today’s lowest price of Global Health Ltd is ₹1113.95.
PE Ratio of Global Health Ltd is 62.78
PE ratio = Global Health Ltd Market price per share / Global Health Ltd Earnings per share
Today’s traded volume of Global Health Ltd(MEDANTA) is 8.60L.
Today’s market capitalisation of Global Health Ltd(MEDANTA) is ₹30628.36Cr.
| Global Health Ltd(MEDANTA | Price |
|---|---|
52 Week High | ₹1513.9 |
52 Week Low | ₹908 |
Global Health Ltd(MEDANTA) share price is ₹1124. It is down -25.75% from its 52 Week High price of ₹1513.9
Global Health Ltd(MEDANTA) share price is ₹1124. It is up 23.79% from its 52 Week Low price of ₹908
| Global Health Ltd(MEDANTA | Returns |
|---|---|
1 Day Returns | -17.25% |
1 Month Returns | 6.59% |
3 Month Returns | 2.13% |
1 Year Returns | 22.32% |